{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:44:14Z","timestamp":1792608254517,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000307","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000}}],"reference-count":363,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000307.pub2","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T17:00:05Z","timestamp":1423242005000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fluphenazine decanoate (depot) and enanthate for schizophrenia"],"prefix":"10.1002","volume":"2016","author":[{"given":"Nicola","family":"Maayan","sequence":"first","affiliation":[{"name":"Enhance Reviews Ltd; Central Office, Cobweb Buildings The Lane, Lyford Wantage UK OX12 0EE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema N","family":"Quraishi","sequence":"additional","affiliation":[{"name":"SQ Therapy; 1 Harley street London UK W1G 9QD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"David","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry; De Crespigny Park PO Box 68 London UK SE5 8AF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aprajita","family":"Jayaswal","sequence":"additional","affiliation":[{"name":"Paras Hospital; Psychiatry; Sushant Lok 1 Gurgoan Haryana India 12201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Eisenbruch","sequence":"additional","affiliation":[{"name":"Monash University; School of Psychology and Psychiatry Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rathbone","sequence":"additional","affiliation":[{"name":"Bond University; Faculty of Health Sciences and Medicine; Robina Gold Coast Queensland Australia 4229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Asher","sequence":"additional","affiliation":[{"name":"Central Office, Cobweb Buildings; Enhance Reviews Ltd; The Lane, Lyford Wantage UK OX12 0EE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive E","family":"Adams","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health Innovation Park, Triumph Road, Nottingham UK NG7 2TU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0001|cit1","first-page":"181","article-title":"Fluphenazine decanoate trial in chronic inpatient schizophrenics failing to absorb oral chlorpromazine","volume":"34","author":"Adamson","year":"1973","journal-title":"Diseases of the Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0002|cit2","first-page":"897","article-title":"Long term double-blind evaluation of pipotiazine palmitate and fluphenazine decanoate","volume":"27","author":"Albert","year":"1980","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00431773","article-title":"Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients","volume":"87","author":"Altamura","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpsyc.1988.01800330046005","article-title":"Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing skills","volume":"45","author":"Asarnow","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00583530","article-title":"Use of the social behaviour assessment schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine","volume":"18","author":"Barnes","year":"1983","journal-title":"Social Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/ajp.130.1.13","article-title":"Depot phenothiazine treatment in acute psychosis: A sequential comparative clinical study","volume":"130","author":"Chien","year":"1973","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0007|cit7","first-page":"148","article-title":"A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients","volume":"Feb-Mar","author":"Chouinard","year":"1978","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1176\/ajp.139.3.312","article-title":"Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: Extrapyramidal symptoms and therapeutic effect","volume":"139","author":"Chouinard","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0010|cit9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00004714-198908000-00003","article-title":"A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia","volume":"9","author":"Chouinard","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0009|cit10","first-page":"108","article-title":"A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia","volume":"20","author":"Chouinard","year":"1984","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0011|cit11","first-page":"41","article-title":"Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanaote","volume":"Suppl 1","author":"Cookson","year":"1986","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.124.4.385","article-title":"Controlled trial of depot fluphenazine in out-patient schizophrenics","volume":"124","author":"Crawford","year":"1974","journal-title":"British Journal of Psychiatry"},{"issue":"776","key":"10.1002\/14651858.CD000307.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(72)91943-5","article-title":"Double-blind trial of fluphenazine decanoate","volume":"2","author":"Curry","year":"1972","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0447.1978.tb06879.x","article-title":"How schizophrenic patients change during 3 years' treatment with depot neuroleptics","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatria Scandanavia"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0447.1978.tb06878.x","article-title":"Three years' maintenance neuroleptic treatment in schizophrenia - before and beyond","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"Suppl","key":"10.1002\/14651858.CD000307.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0447.1973.tb07048.x","article-title":"A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes","volume":"241","author":"Dencker","year":"1973","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0010-440X(76)90012-2","article-title":"Comparison of depot fluphenazines: Duration of action and incidence of side effects","volume":"17","author":"Donlon","year":"1976","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0018|cit18","first-page":"374","article-title":"Double blind trial of fluphenazine decanoate against placebo in ambulant maintenance treatment of chronic schizophrenics","volume":"14","author":"Dotti","year":"1979","journal-title":"Rivista di Psichiatria"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0033291700014318","article-title":"The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs fluphenazine","volume":"8","author":"Fallon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0033291700006632","article-title":"A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia","volume":"8","author":"Falloon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0364-7722(79)90050-X","article-title":"Medical-social evaluation of the long term pharmacotherapy of schizophrenia","volume":"3","author":"Shepherd","year":"1979","journal-title":"Progress Neuro-Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0022|cit22","first-page":"299","article-title":"Double blind controlled trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenia","volume":"16","author":"Feng","year":"1990","journal-title":"Chinese Journal of Nervous and Mental Disorders"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1600-0447.1978.tb06912.x","article-title":"Double blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics","volume":"57","author":"Frangos","year":"1978","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archpsyc.1978.01770340019001","article-title":"Drug and family therapy in the aftercare of acute schizophrenics","volume":"35","author":"Goldstein","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0025|cit25","first-page":"209","article-title":"The interaction between depot-phenothiazines and the social and clinical manifestations of behaviour in patients with stabilised chronic schizophrenia","volume-title":"On the Origin of Schizophrenic Psychoses","author":"Hirsch","year":"1975"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/archpsyc.1979.01780120013001","article-title":"Fluphenazine and social therapy in the aftercare of schizophrenic patients","volume":"36","author":"Hogarty","year":"1979","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archpsyc.1988.01800330021002","article-title":"Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia","volume":"45","author":"Hogarty","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Hranov LG Yanakiev N Stefanov S Nikolova N Yakimova R Haloperidol decanoate and fluphenazine decanoate for schizophrenia: a comparative naturalistic medium term study of efficacy and tolerability 11th Congress of The European College of Neuropsychopharmacology; 1998 Oct 3 - Nov 4; Paris, France 1998","DOI":"10.1016\/S0924-977X(98)80340-4"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0029|cit29","first-page":"585","article-title":"A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients","volume":"18","author":"Jain","year":"1975","journal-title":"Current Therapeutic Research"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0030|cit30","first-page":"69","article-title":"Double blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia","volume":"1","author":"Javed","year":"1991","journal-title":"Pakistan Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bmj.301.6756.837","article-title":"Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years","volume":"301","author":"Jolley","year":"1990","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0032|cit32","first-page":"24","article-title":"A control study on using pipothiazine palmitate to treat schizophrenic patients","volume":"10","author":"Ju","year":"2000","journal-title":"Journal of Clinical Psychological Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1176\/ajp.135.12.1539","article-title":"Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate","volume":"135","author":"Kane","year":"1978","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0035|cit34","first-page":"20","article-title":"Low-dose neuroleptics in outpatient schizophrenics","volume":"18","author":"Kane","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0034|cit35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.1983.01790070083010","article-title":"Low-dose neuroleptic treatment of outpatient schizophrenics","volume":"40","author":"Kane","year":"1983","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0036|cit36","first-page":"15","article-title":"A double blind comparative study on the efficacy and safety of fluphenazine decanoate (SQ10, 733) and oral haloperidol in the treatment of schizophrenic patients","volume":"19","author":"Kaneno","year":"1991","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000468286","article-title":"Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia","volume":"12","author":"Kelly","year":"1977","journal-title":"International Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00402099","article-title":"EEG changes after fluphenazine enanthate and decanoate based on analog power spectra and digital computer period analysis","volume":"20","author":"Keskiner","year":"1971","journal-title":"Psychopharmacologia"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0039|cit39","first-page":"11","article-title":"The effect of fluphenazine decanoate every 2 weeks versus 6 weeks in the treatment of schizophrenia and schizoaffective disorders","volume":"8","author":"Khazaei","year":"2003","journal-title":"Iranian Journal of Psychiatry and Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0040|cit40","first-page":"109","article-title":"Comparative efficacy of every 2 weeks versus every 6 weeks injections of fluphenazine decanoate","volume":"8","author":"Khazaie","year":"2005","journal-title":"Archives of Iranian Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2007-1017373","article-title":"Double-blind comparison of haloperidol and fluphenazine decanoate effectiveness, side effects, dosage and serum levels during a six months treatment for relapse prevention","volume":"18","author":"Kissling","year":"1985","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00332747.1988.11024375","article-title":"Family attitudes and patient social adjustment in a longitudinal study of outpatient schizophrenics receiving low-dose neuroleptics: the family's view","volume":"51","author":"Kreisman","year":"1988","journal-title":"Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00408331","article-title":"A comparative study of two long acting phenothiazine preparations, fluphenazine enanthate and fluphenazine decanoate","volume":"9","author":"Kurland","year":"1966","journal-title":"Psychopharmacologia (Berl)"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2007-1019621","article-title":"Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms","volume":"13","author":"Lehmann","year":"1980","journal-title":"Pharmakopsychiatrie und Neuropsychopharmakologie"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0045|cit45","first-page":"536","article-title":"A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia","volume":"30","author":"Leong","year":"1989","journal-title":"Singapore Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0046|cit46","first-page":"695","article-title":"Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol","volume":"20","author":"Levenson","year":"1976","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08039489009096549","article-title":"Community-based rehabilitation of schizophrenia","volume":"44","author":"Lundin","year":"1990","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08039489209103313","article-title":"Community-based rehabilitation of schizophrenia: corrected version","volume":"46","author":"Lundin","year":"1992","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000117652","article-title":"Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia","volume":"4","author":"MacCrimmon","year":"1978","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0050|cit50","first-page":"109","article-title":"A comparative study of fluspirilene and fluphenazine decanoate in schizophrenic patients","volume":"2","author":"Magnus","year":"1979","journal-title":"Journal of Pharmacotherapy"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0051|cit51","first-page":"1758","article-title":"Fluspirilene and fluphenazine decanoate for schizophrenic patients. Controlled study","volume":"122","author":"Magnus","year":"1980","journal-title":"Munchener Medizinische Wochenschriftenschrift"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0447.1974.tb08047.x","article-title":"A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes","volume":"249","author":"Malm","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.1987.01800180028005","article-title":"Low and conventional dose maintenance therapy with fluphenazine decanoate","volume":"44","author":"Marder","year":"1987","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archpsyc.1983.01790220015002","article-title":"Costs and benefits of two doses of fluphenazine","volume":"41","author":"Marder","year":"1984","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archpsyc.1976.01770120039003","article-title":"Very high dose fluphenazine decanoate","volume":"33","author":"McClelland","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.137.6.510","article-title":"Intermittant pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"137","author":"McCreadie","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.140.3.280","article-title":"Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"140","author":"McCreadie","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.151.3.333","article-title":"Haloperidol decanoate versus fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients","volume":"151","author":"McKane","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0059|cit59","unstructured":"McLaren S Cookson J Silverstone J A comparative trial of bromperidol decanoate and fluphenazine decanoate in chronic Annual Meeting of the British Association for Psychopharmacology; 1990 July 15, Cambridge, England 1990"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0060|cit60","first-page":"67","article-title":"Postive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromoperidol and fluphenazine decanoates","volume":"7","author":"McLaren","year":"1992","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0061|cit61","first-page":"195","article-title":"Double-blind placebo substitution: Withdrawal of fluphenazine decanoate in schizophrenic patients","volume":"43","author":"Odejide","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0447.1979.tb00281.x","article-title":"A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate int he treatment of chronic schizophrenia","volume":"60","author":"Pinto","year":"1979","journal-title":"Acta Psychiatria Scandinavia"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archpsyc.1978.01770310095007","article-title":"Long-acting oral vs injectable antipsychotic drugs in schizophrenics","volume":"35","author":"Quitkin","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0065|cit64","first-page":"40","article-title":"Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics II. Rating scale data","volume":"13","author":"Rifkin","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0064|cit65","first-page":"499","article-title":"The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics","volume":"14","author":"Rifkin","year":"1979","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0066|cit66","first-page":"15","article-title":"Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics - Rating scale data","volume":"34","author":"Rifkin","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1977.01770130045004","article-title":"Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics - Relapse years after one year","volume":"34","author":"Rifkin","year":"1977","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0068|cit68","first-page":"1379","article-title":"Therapeutic evaluation of bromperidol decanoate in schizophrenia - a double-blind comparison vs. Fluphenazine decanoate","volume":"114","author":"Rossi","year":"1990","journal-title":"Rivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/070674378202700714","article-title":"A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia","volume":"27","author":"Russell","year":"1982","journal-title":"Canadian Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0070|cit70","first-page":"642","article-title":"A comparative controlled study of two long-acting phenothiazines: Pipothiazine palmitate and fluphenazine decanoate","volume":"23","author":"Schlosberg","year":"1978","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-1019579","article-title":"Clinical blood chemistry values and long acting phenothiazines","volume":"14","author":"Schneider","year":"1981","journal-title":"Pharmacopsychitria"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0041-1723921","article-title":"The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine","volume":"9","author":"Schooler","year":"1976","journal-title":"Pharmakopsychiatria"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0073|cit73","first-page":"44","article-title":"Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen","volume":"15","author":"Schooler","year":"1979","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/ajp.136.2.217","article-title":"Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate","volume":"136","author":"Gelenberg","year":"1979","journal-title":"Amercian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0075|cit75","first-page":"483","article-title":"Discontinuation of oral and depot fluphenazine in schizophrenic patients ater one year of continuous medication: A controlled study","volume":"24","author":"Levine","year":"1980","journal-title":"Advanced Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archpsyc.1982.04290020051010","article-title":"Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics","volume":"39","author":"Mandel","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0041-1723921","article-title":"The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparison between oral and depot fluphenazine","volume":"9","author":"Schooler","year":"1976","journal-title":"Pharmakopsychiatria"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archpsyc.1980.01780140018002","article-title":"Prevention of relapse in schizophrenia - An evaluation of fluphenazine decanoate","volume":"37","author":"Schooler","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archpsyc.1997.01830170079011","article-title":"Relapse and rehospitalisation during maintenance treatment of schizophrenia: the effects of dose reduction and family treatment","volume":"54","author":"Schooler","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0080|cit80","first-page":"177","article-title":"A comparison of fluphenazine decanoate and haloperidol decanoate in chronic schizophrenia","volume":"2","author":"Sharma","year":"1991","journal-title":"British Journal of Clinical Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004714-198105000-00005","article-title":"Effects of a six-week drug holiday on symptom status, relapse, and tardive dyskinesia in chronic schizophrenics","volume":"1","author":"Shenoy","year":"1981","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0082|cit82","first-page":"141","article-title":"Double-blind study of domestic penfluridol and fluphenazine decanoate","volume":"16","author":"Shu","year":"1983","journal-title":"Chung Hua Shen Ching Ching Shen Ko Tsa Chih (Chinese Journal of Neurology and Psychiatry)"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.1978.01770310099008","article-title":"Standard and long-acting depot neuroleptics in chronic schizophrenics","volume":"35","author":"Simon","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0084|cit84","first-page":"121","article-title":"A comparative study of prolonged action (depot) neuroleptics: pipotiazine palmitate versus fluphenazine enanthate in chronic schizophrenic patients","volume":"25","author":"Singh","year":"1979","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0085|cit85","first-page":"137","article-title":"A double-blind control study on the effect of pipotiazine palmitate and fluphenazine decanoate in the treatment of schizophrenia","volume":"26","author":"Song","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0086|cit86","first-page":"165","article-title":"A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients","volume":"73","author":"Praag","year":"1970","journal-title":"Psychiatria, Neurologia, Neurochirurgia"},{"issue":"7","key":"10.1002\/14651858.CD000307.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1176\/ajp.130.7.801","article-title":"Fluphenazine enanthate and fluphenazine decanoate: A comparison of their duration of action and motor side effects","volume":"130","author":"Praag","year":"1973","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0088|cit88","first-page":"289","article-title":"A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients","volume":"3","author":"Walker","year":"1983","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-0447.1983.tb09718.x","article-title":"Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology","volume":"67","author":"Wistedt","year":"1983","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000307.pub2-BIB0091|cit90","first-page":"15","article-title":"A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients","volume":"1","author":"Wistedt","year":"1986","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0090|cit91","first-page":"804","article-title":"A clinical double-blind comparison between haloperidol decanoate and fluphenazine decanoate","volume":"35","author":"Wistedt","year":"1984","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000468309","article-title":"Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate","volume":"12","author":"Woggon","year":"1977","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0093|cit93","unstructured":"Abuzzahab FS Fluphenazine in chronic schizophrenia Unidentified report 1976 72 3"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0094|cit94","first-page":"26","article-title":"A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"12","author":"Abuzzahab","year":"1976","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0095|cit95","first-page":"71","article-title":"Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"13","author":"Abuzzahab","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0096|cit96","first-page":"547","article-title":"Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl","volume":"24","author":"Abuzzahab","year":"1980","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0097|cit97","unstructured":"Ahlfors UG A double-blind trial with long-acting neuroleptics 5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Ciudad de Mexico, Mexico 1971 80262450"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1973.tb07047.x","article-title":"Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine decanoate","volume":"241","author":"Ahlfors","year":"1973","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0278-5846(87)90022-4","article-title":"Fluphenazine decanoate in acute and maintenance therapy of schizophrenia","volume":"11","author":"Altamura","year":"1987","journal-title":"Progressive Neuro-Psychopharmacological and Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0100|cit100","first-page":"267","article-title":"Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazine decanoate, fluspirilene, penfluridol, perphenazine enanthate and pipothiazine palmitate","volume":"25","author":"Angst","year":"1975","journal-title":"Arzneimittel Forschung"},{"issue":"17","key":"10.1002\/14651858.CD000307.pub2-BIB0101|cit101","first-page":"1015","article-title":"Experience with depot neuroleptics","volume":"not known","author":"Arato","year":"1979","journal-title":"Orvosi Hetilap"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0447.1974.tb09710.x","article-title":"A study of flupenthixol decanoate and pipothiazine undecylenate in schizophrenics","volume":"50","author":"Astrup","year":"1974","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0103|cit103","first-page":"116","article-title":"A comparison of the efficacy of fluphenazine decanoate and hydroxyprotepine decanoate in the treatment of schizophrenia (a double-blind crossover study). 1982;82:116-8","volume":"82","author":"Balon","year":"1982","journal-title":"Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0104|cit104","first-page":"56","article-title":"A comparative study of fluphenazine enanthate and trifluoperazine in chronic schizophrenic patients","volume":"29","author":"Bankier","year":"1968","journal-title":"Diseases of the Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0105|cit105","first-page":"49","article-title":"Efficacy and safety of fluphenthixol decanoate in chronic schizophrenia","volume":"17","author":"Bao","year":"1991","journal-title":"Chinese Journal of Nervous and Mental Disorders"},{"issue":"2-3","key":"10.1002\/14651858.CD000307.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.schres.2010.02.681","article-title":"Large effect of baseline treatment with long acting antipsychotic drugs on randomized treatment outcomes","volume":"117","author":"Barnes","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0107|cit107","first-page":"496","article-title":"A double blind study of fluphenazine enanthate","volume":"26","author":"Barsa","year":"1965","journal-title":"Diseases of the Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0108|cit108","first-page":"531","article-title":"Outcome in 64 chronic psychotics treated with delayed action Moditen or Modecate","volume":"1","author":"Bastie","year":"1974","journal-title":"Annales Medico Psychologiques"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0109|cit109","first-page":"1803","article-title":"High doses of fluphenazine: clinico-therapeutical trials","volume":"92","author":"Benassi","year":"1968","journal-title":"Rivista Sperimentale di Freniatria e Medicina Legale Delle Alienazioni Mentali"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0110|cit110","first-page":"305","article-title":"Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate","volume":"74","author":"Berliner","year":"1974","journal-title":"Acta Psychiatria Belgique"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000307.pub2-BIB0111|cit111","first-page":"49","article-title":"Fluphenazine decanoate and haloperidol decanoate - 2 neuroleptics compared in nonacute psychiatric pathology. Long-term crossover trial. II. Tolerability and side effects","volume":"8","author":"Bilone","year":"1988","journal-title":"Neurologia Psichiatria Scienze Umane"},{"issue":"8","key":"10.1002\/14651858.CD000307.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1176\/appi.ps.55.8.940","article-title":"Use of topical application of lidocaine-prilocaine cream to reduce injection-site pain of depot antipsychotics","volume":"55","author":"Bloch","year":"2004","journal-title":"Psychiatric Services"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1017\/S0767399X0000095X","article-title":"Determinants for clinical activity of neuroleptic drugs: chemical substances, doses, assessment tools","volume":"2","author":"Boyer","year":"1987","journal-title":"Psychiatrie and Psychobiologie"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0114|cit114","unstructured":"Brankovic S Milovanovic S Damjanovic A Paunovic VR No difference between the effects of clozapine and fluphenazine on probabilistic reasoning in paranoid schizophrenia 21st Congress of the Collegium Internationale Neuro-psychopharmacologicum; 1998 Jul 12-16; Glasgow, Scotland 1998 94212428"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1176\/ajp.144.12.1549","article-title":"Neuroleptic responsivity of negative and positive symptoms in schizophrenia","volume":"144","author":"Breier","year":"1987","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0116|cit116","first-page":"132","article-title":"A double-blind evaluation of sulpiride, a new antipsychotic compound","volume":"14","author":"Caranza","year":"1973","journal-title":"American Social Clinical Pharmacological Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-9964(92)90127-Q","article-title":"Novel neuroleptic dosage reduction strategies","volume":"6","author":"Carpenter","year":"1992","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0118|cit118","first-page":"258","article-title":"The effect of dosage interval on the efficacy of fluphenazine decanoate in the prevention of relapse","volume":"9","author":"Carpenter","year":"1993","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1176\/ajp.156.3.412","article-title":"Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks","volume":"156","author":"Carpenter","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0120|cit120","unstructured":"Casacchia M Michele DIV Volonte MV Rossi A Bromperidol decanoate vs fluphenazine decanoate in schizophrenia Psychiatry Today: Accomplishments and Promises. Proceedings of the 8th World Congress of Psychiatry; 1989 Oct 13-19; Athens, Greece 1989 94212428"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0121|cit121","unstructured":"Castellini A Lorini M Flufenazina decanoato e aloperidolo decanoato: due neurolettici a confronto nella patologia psichiatrica non acuta studio crossover a lunga termine not known not known 33 48"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0010-440X(72)90055-7","article-title":"Work study in the assessment of the effects of phenothiazines in schizophrenia","volume":"13","author":"Chacon","year":"1972","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1973.tb04399.x","article-title":"Clinical and work performance variables in phenothiazine therapy of schizophrenia","volume":"49","author":"Chacon","year":"1973","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0124|cit124","first-page":"215","article-title":"Penfluridol versus oral fluphenazine in the maintenance treatment of chronic schizophrenics","volume":"21","author":"Charalampous","year":"1977","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/ajp.131.1.86","article-title":"Antiparkinsonian agents and depot phenothiazine","volume":"131","author":"Chein","year":"1974","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1176\/ajp.120.10.1010","article-title":"Comparison of four regimens in newly admitted female schizophrenics","volume":"120","author":"Childers","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD000307.pub2-BIB0127|cit127","first-page":"598","article-title":"Pimozide in the treatment of chronic schizophrenic patients","volume":"12","author":"Chouinard","year":"1970","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0010-440X(80)90090-5","article-title":"Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics","volume":"21","author":"Chowdhury","year":"1980","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archpsyc.1971.01750170020004","article-title":"Drug treatment in newly admitted schizophrenic patients","volume":"25","author":"Clark","year":"1971","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004714-198512000-00004","article-title":"Plasma levels of neuroleptic in patients receiving depot fluphenazine","volume":"5","author":"Cohen","year":"1985","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0131|cit131","first-page":"369","article-title":"Differences in clinical effects of three phenothiazines in \"acute\" schizophrenia","volume":"446","author":"Cole","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000307.pub2-BIB0132|cit132","first-page":"S24","article-title":"Side effects during long-term treatment with depot antipsychotic medication","volume":"14","author":"Cookson","year":"1991","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0133|cit133","first-page":"269","article-title":"Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice","volume":"23","author":"Coufal","year":"1981","journal-title":"Activa Nervosa Superior (Praha)"},{"issue":"8111","key":"10.1002\/14651858.CD000307.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(79)90749-9","article-title":"Unwanted effects of fluphenazine enanthate and decanoate (letter)","volume":"1","author":"Curry","year":"1979","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.146.5.464","article-title":"Long term depot maintenance of chronic schizophrenic out-patients: The seven year follow-up of the Medical Reseach Council fluphenazine\/placebo trial","volume":"146","author":"Curson","year":"1985","journal-title":"British Journal of Psychiatry"},{"issue":"6549","key":"10.1002\/14651858.CD000307.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.293.6549.726","article-title":"Does short term placebo treatment of chronic schizophrenia produce long term harm?","volume":"293","author":"Curson","year":"1986","journal-title":"British Medical Journal Clinical Research Edition"},{"issue":"6 September","key":"10.1002\/14651858.CD000307.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.3.5670.564","article-title":"Severe depressive mood changes following slow-release intramuscular fluphenazine injection","volume":"3","author":"Alarcon","year":"1969","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0138|cit138","article-title":"Relative safety and efficacy of high and low dose administration of fluphenazine-hcl to psychotic patients","volume-title":"Psychopharmacology Sexual Disorders and Drug Abuse","author":"Buck","year":"1973"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0033-3182(75)71232-X","article-title":"Prevention of recidivism of schizophrenics treated with fluphenazine enanthate","volume":"16","author":"Giudice","year":"1976","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0447.1978.tb06909.x","article-title":"High doses of fluphenazine enanthate in schizophrenia","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"5-6","key":"10.1002\/14651858.CD000307.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/08039488109101727","article-title":"Pharmaco kinetics of fluphenazine depot in megadose: Comparison between the enanthate and the decanoate form","volume":"35","author":"Dencker","year":"1981","journal-title":"Nordic Psykiatria Tidsskria"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0142|cit142","first-page":"977","article-title":"Contribution to the infusion therapy with fluphenazine in schizophrenics with regard to the control of the neuroleptic threshold","volume":"16","author":"Dengler","year":"1969","journal-title":"Medizinische Welt"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0033-3182(71)71533-3","article-title":"Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients: An experimental evaluation","volume":"12","author":"DeWolfe","year":"1971","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1176\/ajp.133.11.1265","article-title":"Depression and the reintegration phase of acute schizophrenia","volume":"133","author":"Donlon","year":"1976","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0145|cit145","first-page":"119","article-title":"Pimozide versus fluphenazine in ambulatory schizophrenics: a 12-month comparison study","volume":"38","author":"Donlon","year":"1977","journal-title":"Diseases of the Nervous System"},{"issue":"11","key":"10.1002\/14651858.CD000307.pub2-BIB0146|cit146","first-page":"800","article-title":"High vs standard dosage fluphenazine HCL in acute schizophrenia","volume":"39","author":"Donlon","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0147|cit147","first-page":"416","article-title":"Penfluridol vs fluphenazine decanaote: A double-blind clinical study in chronic and subchronic schizophrenia","volume":"43","author":"Doongaji","year":"1988","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0148|cit148","unstructured":"Dossenbach M Friedel P Jakovljevic M Hotujac L Folnegovic V Uglesic B Olanzapine versus fluphenazine - six weeks' treatment of acute schizophrenia 10th European College of Neuropsychopharmacology Congress; 1997 Sep 13-17; Vienna, Austria 1997 21196608"},{"issue":"1,2","key":"10.1002\/14651858.CD000307.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0920-9964(97)88822-6","article-title":"Olanzapine versus fluphenazine - 6 weeks treatment of anxiety symptoms during acute schizophrenia","volume":"29","author":"Dossenbach","year":"1998","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2466\/pms.1963.17.2.511","article-title":"Effect of phenothiazines on the thinking of acute schizophrenics","volume":"17","author":"Downing","year":"1963","journal-title":"Perceptual and Motor Skills"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0151|cit151","unstructured":"Emsley R Jones AM Bailey P Raniwalla J 'Seroquel' In partially responsive schizophrenics 11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany 1999 287"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF01537988","article-title":"A double blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children","volume":"3","author":"Engelhardt","year":"1973","journal-title":"Journal of Autism and Childhood Schizophrenia"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08039486909132331","article-title":"Fluphenazine enanthate in long term treatment of psychoses","volume":"23","author":"Engstrand","year":"1969","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0154|cit154","first-page":"167","article-title":"The depot compounds moditen (fluphenazine) and IMAP (flusipirilene) in clinical practice","volume":"16","author":"Faltus","year":"1974","journal-title":"Active Nervosa Superior"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1176\/ajp.126.11.1670","article-title":"Comparison of haloperidol and fluphenazine in disturbed children","volume":"126","author":"Faretra","year":"1970","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0156|cit156","unstructured":"Ferenc M Dossenbach M Jakovljevic M Metcalfe S Predictive value of early anti anxiety effect on the acute antipsychotic outcome: a comparison of fluphenazine and olanzapine 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, USA 2000"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0157|cit157","first-page":"6","article-title":"Oxyprothepin decanoate in maintenance therapy of schizophrenia - a double-blind, standardized controlled study","volume":"81","author":"Filip","year":"1985","journal-title":"Ceskoslovenska Psychiatrie"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0158|cit158","first-page":"31","article-title":"Problem of depressions during long-time neuroleptic treatment of schizophrenia - single blind-study of fluphenazine-decanoate and flupenthixol-decanoate","volume":"5","author":"Floru","year":"1974","journal-title":"Journal De Pharmacologie"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000468199","article-title":"The problem of post-psychotic schizophrenic depressions and pharmacological induction","volume":"10","author":"Floru","year":"1975","journal-title":"International Pharmacopsychiatria"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0160|cit160","first-page":"7","article-title":"Clinical profiles of the effects, indications, preferential therapeutic effect and contraindication of three depot neuroleptics compared in a multicentre trial","volume":"25","author":"Giannelli","year":"1990","journal-title":"Rivista di Psichiatria"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0161|cit161","first-page":"551","article-title":"The effects of fluphenazine decanoate injection and chlorpromazine on symptom severity and learning in outpatient schizophrenics","volume":"29","author":"Gillis","year":"1981","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00004714-198802000-00010","article-title":"Persistance of fluphenazine in plasma after decanoate withdrawal","volume":"8","author":"Gitlin","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","article-title":"Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia","volume":"158","author":"Gitlin","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00213-004-2032-2","article-title":"A six-month, placebo-controlled trial of d-cycloserine co-administered with conventional antipsychotics in schizophrenia patients","volume":"179","author":"Goff","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archpsyc.1967.01730190109015","article-title":"Prediction of improvement in schizophrenia under four phenothiazines","volume":"16","author":"Goldberg","year":"1967","journal-title":"Archives General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0166|cit166","first-page":"153","article-title":"Schizophrenic subtypes defined by response to drugs and placebo","volume":"29","author":"Goldberg","year":"1968","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0033-3182(70)71650-2","article-title":"A clinical evaluation of prolixin enanthate","volume":"11","author":"Goldberg","year":"1970","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0168|cit168","first-page":"116","article-title":"The effects of a drug holiday on relapse and tardive dyskinesia in chronic schizophrenics","volume":"17","author":"Goldberg","year":"1981","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1176\/appi.ajp.163.3.494","article-title":"Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial","volume":"163","author":"Gopalakrishnan","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"Supp","key":"10.1002\/14651858.CD000307.pub2-BIB0170|cit170","first-page":"32","article-title":"Experience of psychiatric management of schizophrenia with fluphenazine decanoate","volume":"31","author":"Grosser","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1192\/bjp.114.512.837","article-title":"A controlled trial of fluphenazine enanthate in hospitalized chronic schizophrennics","volume":"114","author":"Haider","year":"1968","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0172|cit172","first-page":"405","article-title":"A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics","volume":"29","author":"Hall","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00496067","article-title":"A comparative trial of the decanoates of flupenthixol and fluphenazine","volume":"64","author":"Hamilton","year":"1979","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00403632","article-title":"The comparative effectiveness of eight phenothiazines","volume":"7","author":"Hanlon","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2125.1976.tb03713.x","article-title":"Work performance versus clinical assessment in the evaluation of phenothiazine therapy","volume":"3","author":"Harper","year":"1976","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0447.1975.tb00217.x","article-title":"A comparative trial of fluphenazine decanoate and flupenthixol decanoate","volume":"51","author":"Haslam","year":"1975","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-3956(70)90008-7","article-title":"Effect of phenothiazines on reaction time in schizophrenics","volume":"7","author":"Held","year":"1970","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","article-title":"Outpatients maintenance of chronic schizophrenic pateints with long-acting fluphenazine: double-blind placebo trial","volume":"1","author":"Hirsch","year":"1973","journal-title":"British Medical Journal"},{"issue":"5868","key":"10.1002\/14651858.CD000307.pub2-BIB0179|cit179","first-page":"715","article-title":"Outpatient maintenance of chronic schizophrenics with long acting fluphenazine","volume":"17","author":"Hirsch","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0180|cit180","first-page":"792","article-title":"The social value of fluphenazine decanoate","volume":"76","author":"Stevens","year":"1976","journal-title":"Acta Psychitria Belgique"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0181|cit181","first-page":"371","article-title":"Maintenance therapy in out-patient schizophrenics: a report of a double-blind trial comparison of fluphenazine decanoate and flupenthixol decanoate","volume":"133","author":"Hirsch","year":"1978","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/S0007125000295986","article-title":"The dysphoric syndrome in schizophrenia and its implications for relapse","volume":"155","author":"Hirsch","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.1995.03950130029004","article-title":"Pharmacotherapy of impaired affect in recovering schizophrenic patients","volume":"52","author":"Hogarty","year":"1995","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0184|cit184","first-page":"173","article-title":"Assessment and significance of changes in laboratory values with haloperidol and fluphenazine hydrochloride therapy","volume":"2","author":"Holden","year":"1970","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004714-198406000-00003","article-title":"Neuroleptic drug-induced changes in platelet levels","volume":"4","author":"Holt","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0186|cit186","first-page":"807","article-title":"One year study of fluphenazine enanthate","volume":"28","author":"Hsu","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1176\/ajp.151.12.1753","article-title":"A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrneic patients","volume":"151","author":"Inderbitzin","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0920-9964(93)90531-M","article-title":"Most effective dose study (meds): a double - blind reduction trial of fluphenazine decanoate","volume":"9","author":"Inderbitzin","year":"1993","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0189|cit189","first-page":"33","article-title":"Penfluridol in the maintenance therapy of schizophrenia","volume":"21","author":"Ionescu","year":"1983","journal-title":"Neurologie et Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0190|cit190","first-page":"375","article-title":"A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients","volume":"39","author":"Iqbal","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000307.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0006-3223(86)90129-0","article-title":"L-5-Hydroxytryptophan-induced delirium","volume":"21","author":"Irwin","year":"1986","journal-title":"Biological Psychiatry"},{"issue":"5-9","key":"10.1002\/14651858.CD000307.pub2-BIB0192|cit192","first-page":"37","article-title":"Fluphenazine hydrochloride, enanthate, and decanoate in the management of chronic psychosis","volume":"31","author":"Itil","year":"1970","journal-title":"Diseases of the Nervous System"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0033-3182(70)71607-1","article-title":"Treatment of resistant schizophrenics with extreme high dosage fluphenazine hydrochloride","volume":"11","author":"Itil","year":"1970","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1600-0447.1971.tb03701.x","article-title":"Clinical and quantitative EEG changes at different dosage levels of fluphenazine treatment","volume":"47","author":"Itil","year":"1971","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0195|cit195","first-page":"689","article-title":"Pipothiazine palmitate, A long-acting neuroleptic: Clinical and computerized EEG effects","volume":"24","author":"Itil","year":"1978","journal-title":"Current Therapeutic Research"},{"issue":"1-2","key":"10.1002\/14651858.CD000307.pub2-BIB0196|cit196","first-page":"3","article-title":"Olanzapine versus fluphenazine in the acute (six-week) treatment of schizophrenia","volume":"11","author":"Jakovljevic","year":"1999","journal-title":"Psychiatria Danubina"},{"issue":"580","key":"10.1002\/14651858.CD000307.pub2-BIB0197|cit197","first-page":"53","article-title":"Penfluridol: a double blind trial in chronic schizophrenia","volume":"85","author":"James","year":"1977","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0447.1975.tb11092.x","article-title":"A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia","volume":"51","author":"Johnson","year":"1975","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"10","key":"10.1002\/14651858.CD000307.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0200|cit200","first-page":"160","article-title":"Maintenance therapy with fluphenazine decanoate and oxyprothepine decanoate in schizophrenic patients - a DOUBLE blind cross-over comparative study","volume":"22","author":"Kabes","year":"1980","journal-title":"Activitas Nervosa Superior"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0201|cit201","first-page":"16","article-title":"Clinical trial of oxyprothepin decanoate","volume":"76","author":"Kabes","year":"1980","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0202|cit202","first-page":"241","article-title":"Oxyprothepine decanoate in the maintenance treatment of schizophrenia: multiclinical controlled comparison with fluphenazine decanoate","volume":"23","author":"Kabes","year":"1981","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0165-1781(79)90016-7","article-title":"Low dose fluphenazine decanoate in maintenance treatment of schizophrenia","volume":"1","author":"Kane","year":"1979","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archpsyc.1982.04290010048009","article-title":"Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia","volume":"39","author":"Kane","year":"1982","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/9.4.528","article-title":"Low dose medication in the treatment of schizophrenia","volume":"9","author":"Kane","year":"1983","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0206|cit206","unstructured":"Keith SJ Research experience with a long-acting atypical antipsychotic medications Proceedings of the 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA 2002"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0207|cit207","unstructured":"Kelly D Conley RR Sexual side effects of quetiapine and risperidone compared with fluphenazine Stanley Foundation Research Awards - 1999 Research Award Recipients (http:\/\/www.stanleyresearch.org\/ accessed February 2001) 1999 98271218"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0208|cit208","first-page":"69","article-title":"Pimozide compared with fluphenazine in schizophrenia","volume":"25","author":"Kenway","year":"1971","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archpsyc.1968.01740040093012","article-title":"Long acting phenothiazine (fluphenazine decanoate) treatment of psychosis","volume":"18","author":"Keskiner","year":"1968","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0033-3182(68)71862-4","article-title":"Maintenance treatment of schizophrenic outpatients with a depot phenothiazine","volume":"9","author":"Keskiner","year":"1968","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/schbul\/5.1.118","article-title":"Therapists rating of achievement of objectives in psychotherapy with acute schizophrenics","volume":"5","author":"King","year":"1979","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0212|cit212","first-page":"309","article-title":"Treatment of neuroleptic-resistant schizophrenic relapse","volume":"29","author":"Kinon","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1176\/ajp.119.8.779","article-title":"A new method of drug therapy","volume":"119","author":"Kinross-Wright","year":"1963","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.135.6.515","article-title":"Depressive and extrapyramidal symptoms and clinical effects: A trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients","volume":"135","author":"Knights","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0215|cit215","first-page":"371","article-title":"An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia","volume":"5","author":"Kong","year":"1989","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/070674379403900405","article-title":"Fluphenazine treatment of DSM-III-R Male Schizophrenic Patients Among the Xhosa","volume":"39","author":"Landmark","year":"1994","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0217|cit217","first-page":"181","article-title":"Pimozide and the social behavior of schizophrenics","volume":"18","author":"Lapierre","year":"1975","journal-title":"Current Therapeutic Research"},{"issue":"1-2","key":"10.1002\/14651858.CD000307.pub2-BIB0218|cit218","first-page":"8","article-title":"A controlled pimozide, fluphenazine and group psychotherapy study of chronic schizophrenics","volume":"1","author":"Lapierre","year":"1976","journal-title":"Psychiatric Journal of the University of Ottawa"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1176\/ajp.135.8.956","article-title":"A controlled study of penfluridol in the treatment of chronic schizophrenia","volume":"135","author":"Lapierre","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000407841","article-title":"AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics","volume":"2","author":"Lapierre","year":"1983","journal-title":"Modern Problems of Pharmacopsychiatry"},{"issue":"12","key":"10.1002\/14651858.CD000307.pub2-BIB0221|cit221","first-page":"698","article-title":"Drug treatment of schizophrenic patients. A comparitive evaluation of chlorpromazine, chloprothixene, fluphenazine, reserpine, thioridazine and triflupromazine","volume":"23","author":"Lasky","year":"1962","journal-title":"Diseases of the Nervous System"},{"issue":"12","key":"10.1002\/14651858.CD000307.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.3.5775.599","article-title":"Trial of maintenance therapy in schizophrenia","volume":"11","author":"Leff","year":"1971","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1192\/bjp.123.6.659","article-title":"Life events and maintenance therapy in schizophrenic therapy","volume":"123","author":"Leff","year":"1973","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.152.5.765","article-title":"Fluphenazine plasma levels, dosage, efficacy, and side effects","volume":"152","author":"Levinson","year":"1995","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000307.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.1990.01810200069010","article-title":"Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment","volume":"47","author":"Levinson","year":"1990","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1192\/bjp.160.3.365","article-title":"Timing of acute clinical response to fluphenazine","volume":"160","author":"Levinson","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0227|cit227","unstructured":"Lewis S Davies L Jones P Barnes T Murray R Kerwin R Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment Draft final report for NCCHTA 2003"},{"issue":"17","key":"10.1002\/14651858.CD000307.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"iii-iv, ix-xi,","DOI":"10.3310\/hta10170","article-title":"Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment","volume":"10","author":"Lewis","year":"2006","journal-title":"Health Technology Assessment"},{"issue":"17","key":"10.1002\/14651858.CD000307.pub2-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"iii-xi, 1-182","DOI":"10.3310\/hta10170","article-title":"Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment","volume":"10","author":"Lewis","year":"2006","journal-title":"Health Technology Assessment"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-9964(94)90068-X","article-title":"Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia","volume":"12","author":"Litman","year":"1994","journal-title":"Schizophrenia research"},{"issue":"7","key":"10.1002\/14651858.CD000307.pub2-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/1099-1077(200010)15:7<513::AID-HUP213>3.0.CO;2-Y","article-title":"A preliminary study of the comparative effects of olanzapine and fluphenazine on cognition in schizophrenic patients","volume":"15","author":"Ljubin","year":"2000","journal-title":"Human Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00044011-200424050-00004","article-title":"Risperidone versus conventional antipsychotics for schizophrenia and schizoaffective disorder: symptoms, quality of life and resource use under customary clinical care","volume":"24","author":"Mahmoud","year":"2004","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00178510","article-title":"Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate","volume":"88","author":"Marder","year":"1986","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0234|cit234","first-page":"479","article-title":"Plasma levels of parent drug and metabolites in patients recieving oral and depot fluphenazine","volume":"25","author":"Marder","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0235|cit235","first-page":"256","article-title":"Fluphenazine plasma levels and clinical response","volume":"26","author":"Marder","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1192\/bjp.158.5.658","article-title":"Plasma levels of fluphenazine in patients receiving fluphenazine decanoate","volume":"158","author":"Marder","year":"1991","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0237|cit237","first-page":"79","article-title":"Early prediction of relapse in schizophrenia: An application of receiver operating characteristic (ROC) methods","volume":"27","author":"Marder","year":"1991","journal-title":"Psychopharmalogical Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/ajp.153.12.1585","article-title":"Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia","volume":"153","author":"Marder","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0920-9964(00)00184-5","article-title":"Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate","volume":"53","author":"Marder","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-9964(00)90767-9","article-title":"Predictive value of early anti anxiety effect on the acute antipsychotic outcome: a comparison of fluphenazine and olanzapine","volume":"41","author":"Martenyi","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0241|cit241","first-page":"705","article-title":"Comparative study of the action of fluphenazine oenanthate and decanoate in chronic psychoses (73 cases)","volume":"2","author":"Martin","year":"1972","journal-title":"Annales Medico Psychologiques"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0242|cit242","first-page":"445","article-title":"Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives","volume":"19","author":"Mattes","year":"1984","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/S0007125000116691","article-title":"Weekly pimozide versus fluphenazine decanoate in schizophrenic out and day patients","volume":"143","author":"McCreadie","year":"1983","journal-title":"British Journal of PSychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000307.pub2-BIB0244|cit244","first-page":"13","article-title":"Depot neuroleptics as maintenance therapy in chronic schizophrenic in-patients","volume":"1","author":"McCreadie","year":"1986","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0245|cit245","first-page":"155","article-title":"Haloperidol decanoate (a new depot neuroleptic drug): double-blind study versus fluphenazine decanoate in schizophreniform disorders and chronic schizophrenia","volume-title":"Schizophrenia: an Intergrative View","author":"Meco","year":"1987"},{"issue":"1,2","key":"10.1002\/14651858.CD000307.pub2-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0920-9964(97)88682-3","article-title":"Olanzapine compared to fluphenazine in the treatment of schizophrenia","volume":"29","author":"Mimica","year":"1998","journal-title":"Schizophrenia Research"},{"issue":"10","key":"10.1002\/14651858.CD000307.pub2-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","article-title":"Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics","volume":"7","author":"Montejo","year":"2010","journal-title":"Journal of Sexual Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1192\/bjp.117.541.683","article-title":"A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia","volume":"117","author":"Morris","year":"1970","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","article-title":"Phenothiazine treatment in acute schizophrenia","volume":"10","author":"National Institute of Mental Health Psychopharmacology Service Center Collaborative Study Group","year":"1964","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000468334","article-title":"Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial","volume":"13","author":"Nestoros","year":"1978","journal-title":"International Pharmacopsychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000307.pub2-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archpsyc.1993.01820200046005","article-title":"Effects of clozapine and fluphenazine treatment on responses to m chlorophenylpiperazine infusions in schizophrenia","volume":"50","author":"Owen","year":"1993","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0252|cit252","first-page":"29","article-title":"Flupentixol decanoate versus other neuroleptics in chronic schizophrenia","volume":"35","author":"Palma Wenzel","year":"1997","journal-title":"Revista Chilena de Neuropsiquiatria"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0253|cit253","first-page":"312","article-title":"A double blind, controlled, multicenter trial of low dose amisulpride (Solian(R) 50) versus low dose fluphenazine in the treatment of negative symptoms in chronic schizophrenia","volume":"3","author":"Pichot","year":"1988","journal-title":"Annales de Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S0767399X00000912","article-title":"Profiles of the pharmacologic response of positive and negative symptoms in schizophrenia","volume":"2","author":"Pickar","year":"1987","journal-title":"Psychiatrie and Psychobiologie"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archpsyc.1992.01820050009001","article-title":"Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine","volume":"49","author":"Pickar","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1994.03950020083008","article-title":"Clinical response to clozapine in patients with schizophrenia","volume":"51","author":"Pickar","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1176\/ajp.121.1.73","article-title":"Clinical trial of fluphenazine enanthate- A long-acting injectable tranquilizer","volume":"121","author":"Pollack","year":"1964","journal-title":"American Jornal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0258|cit258","first-page":"204","article-title":"Psychometric performance of clozapine and fluphenazine treated schizophrenics","volume":"28","author":"Preussler","year":"1995","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0259|cit259","first-page":"207","article-title":"Psychometric performance of chronic schizophrenics treated with a typical neuroleptic (fluphenazine) or an atypical neuroleptic drug (clozapine) - a double-blind controlled clinical trial","volume":"30","author":"Preussler","year":"1997","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1002\/14651858.CD000307.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archpsyc.1975.01760280074007","article-title":"Very high dosage vs standard dosage fluphenazine in schizophrenia. A double-blind study of nonchronic treatment-refractory patients","volume":"32","author":"Quitkin","year":"1975","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0261|cit261","first-page":"27","article-title":"A one year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple episode schizophrenics","volume":"12","author":"Quitkin","year":"1977","journal-title":"Psychopharmacological Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0262|cit262","first-page":"33","article-title":"A controlled study of fluphenazine enanthate in chronic schizophrenic patients","volume":"25","author":"Ravaris","year":"1965","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0263|cit263","first-page":"248","article-title":"Further studies with fluphenazine enanthate: II. Relapse rate in patients deprived of medication","volume":"124","author":"Ravaris","year":"1967","journal-title":"Americal Journal of Psychology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0264|cit264","first-page":"24","article-title":"Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics","volume":"12","author":"Rifkin","year":"1976","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0265|cit265","first-page":"216","article-title":"Haloperidol decanoate as a replacement therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses","volume":"82","author":"Roose","year":"1982","journal-title":"Acta Psychiatria Belgique"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0266|cit266","first-page":"212","article-title":"Neuropsychological test performance of chronic schizophrenics treated with clozapine or fluphenazine - a double-blind, controlled clinical trial","volume":"30","author":"Rossger","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0267|cit267","unstructured":"Saxena B The value of depot neuroleptic injections in the treatment of chronic schizophrenia. Conference: schizophrenia 1996: Breaking down the barriers, 4th International Conference, Vancouver, B.C Breaking down the barrires, 4th International Conference, Vancouver, B.C., Canada October 6-9, 1996 1996"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1016\/S0924-977X(99)80357-5","article-title":"Impact of olanzapine versus fluphenazine on patient's drug acceptance during acute treatment of schizophrenia","volume":"9","author":"Schausberger","year":"1999","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0269|cit269","doi-asserted-by":"crossref","unstructured":"Schausberger B Folnegovic-Smalc V Hotujac L Uglesic B Jakovljevic M Dossenbach M Impact of olanzapine vs. Fluphenazine on patient's drug acceptance during acute treatment of schizophrenia 11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany 1999","DOI":"10.1016\/S0924-977X(99)80357-5"},{"issue":"16","key":"10.1002\/14651858.CD000307.pub2-BIB0270|cit270","first-page":"707","article-title":"Depot neuroleptics in the treatment of schizophrenia","volume":"115","author":"Schipper","year":"1971","journal-title":"Nederlands Tijdschrift Voor Geneeskunde"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archpsyc.1971.01750140042008","article-title":"Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines","volume":"25","author":"Schooler","year":"1971","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0272|cit272","first-page":"29","article-title":"Dosage and side effect comparisons between oral and depot fluphenazine","volume":"13","author":"Schooler","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/978-3-663-01928-2_4","article-title":"On minus symptoms in chronic schizophrenic patients and their reactions to neuroleptic drugs","volume-title":"Schizophrene Erkrankungen. Therapie Therapieresistenz eine Standortbestimmung","author":"Schubert","year":"1988"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3371\/CSRP.3.2.4","article-title":"Augmentation of olanzapine by fluphenazine decanoate in poorly responsive schizophrenia","volume":"3","author":"Shafti","year":"2009","journal-title":"Clinical Schizophrenia and Related Psychoses"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0447.1970.tb02069.x","article-title":"A controlled comparison of the treatment of schizophrenic patients when treated according to the neurologic threshold or by clinical judgment","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0276|cit276","unstructured":"Siris SG Bermanzohn PC Gonzalez A Mason SE White CV Shuwall MA The use of antidepressants for negative symptoms in a subset of schizophrenic-patients Proceedings of the 29th Annual Meeting of the American College of Neuropsychopharmacology San Juan Us Government Printing Office 1990 331 5"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0277|cit277","unstructured":"Siris SG Bermanzohn PC Mason SE Shuwall MA Maintenance imipramine therapy for secondary depression in schizophrenia - a controlled trial Proceedings of the 30th Annual Meeting of the American College of Neuropsychopharmacology; 1991 Dec 10 San Juan American Medical Association 1991 109 15"},{"issue":"11","key":"10.1002\/14651858.CD000307.pub2-BIB0278|cit278","first-page":"470","article-title":"A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse","volume":"55","author":"Steingard","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0033291700048480","article-title":"Role of fluphenazine decanaote in lessening the burden of chronic schizophrenics on the community","volume":"3","author":"Stevens","year":"1973","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-2007-1017319","article-title":"A comparative trial of CIS(Z)-clopenthixol decanoate and fluphenazine decanoate","volume":"18","author":"Tegeler","year":"1985","journal-title":"Pharmacopsychiatria"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/070674376901400212","article-title":"Comparative study of fluphenazine ethanate, fluphenazine bichlorhydrate and placebos in chronic schizophrenics","volume":"14","author":"Tretreault","year":"1969","journal-title":"Canadian Psychiatric Associative Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"109S","DOI":"10.1016\/S0006-3223(98)90811-3","article-title":"Olanzapine versus fluphenazine: treatment of acute schizophrenic symptomatology and anxiety","volume":"43","author":"Tran","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0283|cit283","unstructured":"Tran PV Tollefson GD Crawford AM Dossenbach M Friedel P Folnegovic V Olanzapine versus fluphenazine in schizophrenia 151st Annual Meeting of the American Psychiatric Association; 1998 May 30-Jun 4; Toronto, Canada 1998"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2003.09.012","article-title":"Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia","volume":"55","author":"Tsai","year":"2004","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biopsych.2005.06.032","article-title":"D-alanine added to antipsychotics for the treatment of schizophrenia","volume":"59","author":"Tsai","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.2042-7158.1966.tb07825.x","article-title":"A comparison of fluphenazine and chlorpromazine on critical flicker fusion frequency","volume":"18","author":"Turner","year":"1966","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.yic.0000133500.92025.20","article-title":"Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics","volume":"19","author":"Turner","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD000307.pub2-BIB0288|cit288","first-page":"99","article-title":"Neurophysiological dynamics in the treatment of endogenous depression using reflexotherapy","volume":"90","author":"Ushakov","year":"1990","journal-title":"Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova"},{"issue":"Suppl","key":"10.1002\/14651858.CD000307.pub2-BIB0289|cit289","first-page":"12","article-title":"Low-dose treatment strategies","volume":"47","author":"Putten","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0290|cit290","first-page":"91","article-title":"Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients","volume":"27","author":"Putten","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0291|cit291","first-page":"260","article-title":"Generic substitution: comparing the clinical efficacy of a generic substitute for fluphenazine decanoate with the original product","volume":"88","author":"Verster","year":"1998","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0292|cit292","first-page":"149","article-title":"A comparison of fluphenazine, triflupromazine, and phenobarbital in the treatment of chronic schizophrenic patients: a double-blind controlled study","volume":"23","author":"Vestre","year":"1962","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00174677","article-title":"Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate","volume":"94","author":"Viala","year":"1988","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD000307.pub2-BIB0294|cit294","first-page":"819","article-title":"A controlled study of fluspirilene in chronic schizophrenia","volume":"12","author":"Villeneuve","year":"1970","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0295|cit295","first-page":"248","article-title":"Long acting peroral fluphenazine and its dosage in psychoses","volume":"12","author":"Vinar","year":"1970","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0296|cit296","first-page":"269","article-title":"Stabilization and depot neuroleptic dosages","volume":"29","author":"Weiden","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF02244140","article-title":"Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia","volume":"101","author":"Wiles","year":"1990","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD000307.pub2-BIB0298|cit298","first-page":"377","article-title":"A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia","volume":"27","author":"Winter","year":"1973","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0300|cit299","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1981.tb00761.x","article-title":"A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients","volume":"64","author":"Wistedt","year":"1981","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0299|cit300","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00433729","article-title":"A depot withdrawal study. Palsma concentration of fluphenazine and flupenthixol and relapse frequency","volume":"78","author":"Wistedt","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0301|cit301","first-page":"369","article-title":"Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics","volume":"44","author":"Wistedt","year":"1983","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00427950","article-title":"A depot neuroleptic withdrawal study neurological effects","volume":"80","author":"Wistedt","year":"1983","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0303|cit303","first-page":"243","article-title":"Maintenance treatment of schizophrenia with oxyprothepine decanoate: double-blind comparison with standard","volume":"23","author":"Zapletalek","year":"1981","journal-title":"Activis Nervosa Superior (Praha)"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-0028-1094363","article-title":"The depot neuroleptic agent fluspirilene","volume":"6","author":"Angst","year":"1973","journal-title":"Pharmakopsychiatrie und Neuropsychopharmakologie"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0305|cit305","unstructured":"del Giudice J Okun R Clark WG Recidivism with long acting fluphenazine VII meeting of the International College of Neuropsychopharmacology 1970 21196608"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0306|cit306","first-page":"19","article-title":"Flupentixol vs fluphenazine in schizophrenia patients: a randomized controlled trial","volume":"15","author":"Jue","year":"1996","journal-title":"New Drugs and Clinical Remedies"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0307|cit307","first-page":"159","article-title":"A multiclinical study of the effectiveness of meclopin in maintenance therapy of schizophrenic patients - A DOUBLE-blind crossover comparative study with flufenazine decanoate","volume":"30","author":"Kabes","year":"1984","journal-title":"Farmakoterapeuticke Zpravy"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0308|cit308","first-page":"XLVI","article-title":"Antipsychotic efficacy of clozapine vs fluphenazine in positive and negative schizophrenia syndrome","volume":"103","author":"Ravanic","year":"1996","journal-title":"Journal of Neural Transmission"},{"issue":"7","key":"10.1002\/14651858.CD000307.pub2-BIB0309|cit309","first-page":"99","article-title":"Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia","volume":"90","author":"Ushakov","year":"1990","journal-title":"Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0310|cit310","doi-asserted-by":"crossref","unstructured":"Aaes-Jorgenson A Pharmacokinetics of oral and depot neuroleptics-Clinical relevance Symposium Espo, 1985 Feb 1","DOI":"10.1007\/978-1-4613-2363-1_112"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0311|cit311","unstructured":"Alderson P Green S Higgins JPT Cochrane Reviewers' Handbook 4.2.2 [updated December 2003] The Cochrane Library 2004"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Statistics Notes: Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0313|cit313","volume-title":"The Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1983"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0314|cit314","volume-title":"The Scale for the Assessment of Positive Symptoms (SAPS)","author":"Andreasen","year":"1984"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1978.tb02357.x","article-title":"A comprehensive psychopathological rating scale","volume":"Supp 271","author":"Asberg","year":"1978","journal-title":"Acta Psychiatria Scandinavca"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2165\/00002018-199410060-00005","article-title":"Long term depot antipsychotics. A risk benefit assessment","volume":"10","author":"Barnes","year":"1994","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD000307.pub2-BIB0318|cit318","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-1781(97)03031-X","article-title":"The Maryland Psychiatric Research Center scale and the characterization of involuntary movements","volume":"70","author":"Cassady","year":"1997","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0320|cit320","first-page":"233","article-title":"Extrapyramidal symptom rating scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0321|cit321","volume-title":"The Neuropsychology of Schizophrenia","author":"David","year":"1994"},{"issue":"1Suppl","key":"10.1002\/14651858.CD000307.pub2-BIB0322|cit322","first-page":"2S","article-title":"The natural course of schizophrenia and effective maintenance drug therapy","volume":"6","author":"Davis","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"670","key":"10.1002\/14651858.CD000307.pub2-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.3.5670.564","article-title":"Severe depressive mood changes following slow-release intramuscular fluphenazine injection","volume":"3","author":"Alarcon","year":"1969","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0324|cit324","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town Cape Town The Cochrane Collaboration 2000"},{"issue":"supp 279","key":"10.1002\/14651858.CD000307.pub2-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0447.1980.tb07084.x","article-title":"Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study","volume":"61","author":"Dencker","year":"1980","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0326|cit326","unstructured":"Derogatis LR SCL-90-R: Administration, procedures and scoring manual, for the revised version Clinical Psychometrics Reasearch Unit , John Hopkins University, Baltimore 1977"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0328|cit328","unstructured":"Department of Health Burdens of Disease: a Discussion Document Department of Health. NHS Executive 1996"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD000307.pub2-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for use in psychiatric research","volume":"26","author":"Feighner","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000307.pub2-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0336|cit336","volume-title":"Clinincal Global Impression (CGI). In: Early clinical drug evaluation (ECDUE) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0337|cit337","volume-title":"Compliance in health care","author":"Haynes","year":"1979"},{"issue":"3","key":"10.1002\/14651858.CD000307.pub2-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: an instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrich","year":"1984","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0340|cit340","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org."},{"key":"10.1002\/14651858.CD000307.pub2-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","article-title":"Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo controlled trial","volume":"1","author":"Hirsch","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0342|cit342","first-page":"799","article-title":"NOSIE-30: A treatment sensitive ward behavior scale","volume":"10","author":"Honigfeld","year":"1962","journal-title":"Psychological Reports"},{"issue":"1","key":"10.1002\/14651858.CD000307.pub2-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2009.07707.x","article-title":"Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials","volume":"146","author":"Hutton","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0264180100000904","article-title":"Schizophrenia: manifestations, incidence and course indifferent cultures","volume":"20","author":"Jablensky","year":"1992","journal-title":"Psychological Medicine Monograph Supplement"},{"issue":"suppl 5","key":"10.1002\/14651858.CD000307.pub2-BIB0345|cit345","first-page":"30","article-title":"Depot neuroleptics: A comparison review of standard, intermediate and low-dose regimens","volume":"47","author":"Kane","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia","volume":"8","author":"Kane","year":"1998","journal-title":"European Neuropschopharmacology"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0347|cit347","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","article-title":"A standardised psychiatric assessment scale for rating psychotic patients","volume":"55","author":"Krawiecka","year":"1977","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"Supp9","key":"10.1002\/14651858.CD000307.pub2-BIB0349|cit349","first-page":"18","article-title":"The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics","volume":"31","author":"Kurland","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0350|cit350","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD000307.pub2-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0352|cit352","first-page":"1","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta PsychiatrIa Scandinavica Supplement"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0353|cit353","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archpsyc.1983.01790220015002","article-title":"Costs and benefits of two doses of fluphenazine","volume":"41","author":"Marder","year":"1984","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0354|cit354","first-page":"256","article-title":"Fluphenazine plasma levels and clinical response","volume":"26","author":"Marder","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0355|cit355","unstructured":"Marshall Personal communication Email 1998"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0359|cit359","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD000307.pub2-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD000307.pub2-BIB0361|cit361","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"7","key":"10.1002\/14651858.CD000307.pub2-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000307.pub2-BIB0363|cit363","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000307","article-title":"Depot fluphenazine decanoate and enanthate for schizophrenia","author":"David","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000307.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:03:07Z","timestamp":1762448587000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000307.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":363,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000307.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}